Articles > Healthcare & Insurance
We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.
A new study recently released by the National Health Service in the United Kingdom showed that people with type 1 diabetes are significantly more likely to die in the hospital setting from COVID-19 than people living with type 2 diabetes.
The ongoing outbreak of the novel respiratory disease COVID-19 has become a significant threat to global health and individuals with pre-existing medical conditions. To gain a deeper understanding of how the coronavirus is affecting people with type 1 diabetes, T1D Exchange is leading a first-of-its-kind COVID-19 research surveillance study in partnership with more than 50 …
The last few weeks have been a harrowing experience for thousands of people around the world. The public health crisis caused by the novel coronavirus COVID-19 threatens to overwhelm doctors and hospitals with an alarming number of deaths and infections.
As the novel coronavirus COVID-19 continues to spread in the United States, many people are understandably concerned about access to their medications. Health officials and medical professionals working in federal, state and local governments recommend that high-risk individuals with underlying health conditions such as Type 1 Diabetes, stock up on their prescription medications, in addition to practicing basic hygiene and avoiding crowded places.
Last month, the FDA approved the Tandem Diabetes Care update to its t:slim X2 insulin pump Control-IQ technology, clearing the way for the first automated and interoperable insulin dosing system on the U.S. market.
Qualifying plans which offer the option of health savings accounts can provide pre-deductible coverage for some care for chronic conditions like diabetes, according to a new rule issued by the U.S. Treasury Department.
A profile of Dr. Michael Heile of The Family Medical Group-Cincinnati.
The groundbreaking legislation does not put a similar limit on insulin costs for those who lack insurance, however.
If the Fifth Circuit Court of Appeals agrees, this could put the health care coverage for many people with type 1 diabetes at risk.
